Phase I study of AD-214
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2019
Price : $35 *
At a glance
- Drugs AD-214 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- 06 Sep 2019 Planned initiation date changed to 1 Jan 2020.
- 04 Sep 2019 According to an AdAlta media release, the company expects to commence this study in early 2020 following the release of the current toxicity study data.
- 04 May 2018 New trial record